ArticleEuropean journal of heart failure2020

Evaluation of high-sensitivity C-reactive protein and uric acid in vericiguat-treated patients with heart failure with reduced ejection fraction.

Frank Kramer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.